Approximately 30% of the samples from various human malignancies show GALNT14 overexpression, and GALNT14 affects the O-glycosylation of death receptors in cancer cells and modulates sensitivity to cancer therapy [4]. The gene discussed is GALNT14; the disease is cancer.